Australian women now spend over one-third of their lives in the post-menopausal phase, yet menopause remains under-recognized in routine healthcare.1 Midlife is a critical window of opportunity to address the increased risk of chronic conditions such as cardiovascular disease, osteoporosis, type 2 diabetes, mood disorders, and certain cancers. Despite this, structured perimenopause and menopause consultations are often not yet standard practice in primary care, which could mean missed opportunities for early intervention and symptom management.
While menopause is a unique experience for each woman, up to 80% experience symptoms, and 20% report severe, life-altering impacts on their quality of life.2 The recent 2024 Senate Inquiry into menopause and perimenopause highlighted issues relating to accessing adequate healthcare for women during this life stage.1
There is evidence many women may not be fully aware of or have access to the full range of evidence-based treatment options to support menopause symptom control. For example, in 2024, only 4% of women in their 50s in our region were using menopausal hormone therapy (MHT).3 While it may not be needed or appropriate for all women, MHT is the most effective way to control menopausal symptoms.2
An informed decision-making process, which includes discussing the risks and benefits of both hormonal and non-hormonal options, is essential for tailoring approaches to women during the menopausal transition.
This toolkit is designed to equip primary care providers with evidence-based strategies to initiate timely conversations, assess individual risk factors and implement effective interventions that empower women to age well.